Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Andalan Sakti Primaindo Tbk (ASPI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Andalan Sakti Primaindo TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Andalan Sakti Primaindo Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Andalan Sakti Primaindo Tbk trades at Rp535 (market cap 340.91B, 1.84M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Andalan Sakti Primaindo Tbk is more actively traded (1.84M versus 1.44M). Which is the better fit depends on your goals.

ASPILABS
Market Cap
340.91B584.6B
Volume
1.84M1.44M
Lot
18.36K14.4K
Turnover
934.18M209.72M
Average Price
508.81145.64
Value
934.18M209.72M
Indicative Equilibrium Price
535146
Indicative Equilibrium Volume
348753

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASPI
View details
LABS
View details

About Andalan Sakti Primaindo Tbk

PT. Andalan Sakti Primaindo Tbk. ("the Company") was established based on the Notarial Deed of Saniwati Suganda, S.H., No.81 dated 13 November 2012. Entiry parent is PT Andalan Sakti Inti.

Read more on ASPI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS